Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kah-Whye Peng

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Blood|December 30, 2015
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemiaWeiwei Shen, Mrinal M Patnaik, Autumn Ruiz, et al.
Cancer Treatment and Research Communications|October 21, 2021
Oncolytic virotherapy - Forging its place in the immunomodulatory paradigm for Multiple MyelomaJoselle Cook, Aldo A Acosta-Medina, Kah Whye Peng, et al.
Experimental Hematology|February 14, 2013
Enhancing cytokine-induced killer cell therapy of multiple myelomaChunsheng Liu, Lukkana Suksanpaisan, Yun-Wen Chen, et al.
Journal of Virology|May 16, 2014
Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virusCamilo Ayala-Breton, Luke O J Russell, Stephen J Russell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2020
Improved Noninvasive In Vivo Tracking of AAV-9 Gene Therapy Using the Perchlorate-Resistant Sodium Iodide Symporter from Minke WhaleSusanna C Concilio, Lukkana Suksanpaisan, Linh Pham, et al.
Scientific Reports|August 8, 2013
Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapyYu-Ping Liu, Lukkana Suksanpaisan, Michael B Steele, et al.
Future Virology|February 2, 2018
Designing and building oncolytic virusesJustin Maroun, Miguel Muñoz-Alía, Arun Ammayappan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Engineering oncolytic measles virus to circumvent the intracellular innate immune responseIana Haralambieva, Ianko Iankov, Kosei Hasegawa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 12, 2013
Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spreadCamilo Ayala-Breton, Lukkana Suksanpaisan, Emily K Mader, et al.
Cell Reports. Medicine|December 18, 2024
Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug-controllable interleukin 12Haifei Jiang, Rebecca Nace, Coryn Ferguson, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Blood|December 30, 2015
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemiaWeiwei Shen, Mrinal M Patnaik, Autumn Ruiz, et al.
Cancer Treatment and Research Communications|October 21, 2021
Oncolytic virotherapy - Forging its place in the immunomodulatory paradigm for Multiple MyelomaJoselle Cook, Aldo A Acosta-Medina, Kah Whye Peng, et al.
Experimental Hematology|February 14, 2013
Enhancing cytokine-induced killer cell therapy of multiple myelomaChunsheng Liu, Lukkana Suksanpaisan, Yun-Wen Chen, et al.
Journal of Virology|May 16, 2014
Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virusCamilo Ayala-Breton, Luke O J Russell, Stephen J Russell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2020
Improved Noninvasive In Vivo Tracking of AAV-9 Gene Therapy Using the Perchlorate-Resistant Sodium Iodide Symporter from Minke WhaleSusanna C Concilio, Lukkana Suksanpaisan, Linh Pham, et al.
Scientific Reports|August 8, 2013
Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapyYu-Ping Liu, Lukkana Suksanpaisan, Michael B Steele, et al.
Future Virology|February 2, 2018
Designing and building oncolytic virusesJustin Maroun, Miguel Muñoz-Alía, Arun Ammayappan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Engineering oncolytic measles virus to circumvent the intracellular innate immune responseIana Haralambieva, Ianko Iankov, Kosei Hasegawa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 12, 2013
Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spreadCamilo Ayala-Breton, Lukkana Suksanpaisan, Emily K Mader, et al.
Cell Reports. Medicine|December 18, 2024
Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug-controllable interleukin 12Haifei Jiang, Rebecca Nace, Coryn Ferguson, et al.
Pageof 12